-

Mark Lanier Named Among State’s Top Attorneys by Texas Super Lawyers

Lanier Law Firm equals firm record with 17 Texas Super Lawyers in 2026

HOUSTON--(BUSINESS WIRE)--Mark Lanier, founder of The Lanier Law Firm in Houston, has been named once again among the Top 10 attorneys in the state by the editors of Texas Super Lawyers. Consistently recognized as one of the nation’s top trial lawyers, he has helped secure nearly $20 billion for clients and was recognized by the publication for excellence in Class Action/Mass Torts proceedings. Earlier this year Mr. Lanier served as lead trial counsel in securing a landmark $6 million verdict in the first social media addiction lawsuit to reach a jury.

His consecutive years of recognition by Texas Super Lawyers began with the inaugural list in 2003, and this year is his 19th appearance on the Top 10 list.

In addition to the honor for Mr. Lanier, the firm has a record number of 17 attorneys named to the Texas Super Lawyers and Texas Rising Stars guide for 2026, recognizing the firm’s success across five practice areas.

“These awards reflect the depth of talent and dedication in our firm,” Mr. Lanier said. “It is an honor to work alongside these colleagues in service to our clients and to be recognized for our efforts by Super Lawyers.”

Firm attorneys were recognized for excellence in Appellate Practice, Business Litigation, General Litigation, Class Action/Mass Torts and Personal Injury General: Plaintiff.

The firm’s Texas Super Lawyers are:

The 2026 Texas Rising Stars honorees are:

Texas Super Lawyers uses nominations, peer reviews, professional accomplishments and staff research to honor the top 5% of attorneys. Rising Stars recognizes 2.5% of lawyers under 40 or with 10 years or less in practice.

About The Lanier Law Firm
For more than 30 years, The Lanier Law Firm has represented clients nationwide in high-stakes litigation involving business disputes, mass torts, personal injury, defective products, asbestos exposure, and more. Named an Elite Trial Law Firm by The National Law Journal, the firm has offices in Houston, Fort Worth, New York, and Los Angeles. Learn more at www.lanierlawfirm.com.

Contacts

Media Contact:
Kevin Roberts
713-659-5200
Media@lanierlawfirm.com

The Lanier Law Firm


Release Versions

Contacts

Media Contact:
Kevin Roberts
713-659-5200
Media@lanierlawfirm.com

More News From The Lanier Law Firm

The Lanier Law Firm Named Mass Tort and Class Actions Law Firm of the Year

HOUSTON--(BUSINESS WIRE)--The Lanier Law Firm has earned the esteemed Law Firm of the Year award from Best Law Firms as the nation’s top legal practice for plaintiffs mass tort litigation and class actions. Along with this achievement, the firm retained its national honor in appellate practice. The firm’s offices in Houston, New York City and Los Angeles also earned placements in the guide for excellence across 10 practice areas. The Houston office earned Tier 1 rankings, the highest possible,...

Attorney Mark Lanier Calls for Social Media Companies to Make Meaningful Changes in Wake of Meta, Snap Settlements

LOS ANGELES--(BUSINESS WIRE)--While settlements have been reached with Meta Platforms Inc. and Snap Inc. in advance of the second bellwether trial over alleged addictive behaviors and mental health damages affecting young users of social media, lead trial attorney Mark Lanier says the companies must do more. "Families shouldn’t have to go jury by jury to solve a problem this big," says Mr. Lanier. "What these teenagers need is a permanent fix, real design changes that protect kids, not case-by-...

The Lanier Law Firm Supports Attorney General Ken Paxton in Reaching $45 Million Settlement with Gilead in Unlawful Inducement Scheme

HOUSTON--(BUSINESS WIRE)--Building on decades of holding pharmaceutical companies responsible for dangerous products and unlawful business practices, The Lanier Law Firm played a pivotal role supporting Texas Attorney General Ken Paxton in securing a $45 million settlement with Gilead Sciences, Inc. Announced on Oct. 22, the settlement resolves claims that the company offered illegal incentives to medical providers to prescribe its drugs over competitors’ medications. In many cases, these presc...
Back to Newsroom